APA (7th ed.) Citation

Teplyakov, A. T., Kuznetsova, A. V., Protopopova, N. V., Andriyanova, A. V., Suslova, T. E., Nasanova, O. N., & Kalyuzhin, V. V. LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE? Siberian State Medical University (Tomsk).

Chicago Style (17th ed.) Citation

Teplyakov, A. T., A. V. Kuznetsova, N. V. Protopopova, A. V. Andriyanova, T. E. Suslova, O. N. Nasanova, and V. V. Kalyuzhin. LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE? Siberian State Medical University (Tomsk).

MLA (9th ed.) Citation

Teplyakov, A. T., et al. LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE? Siberian State Medical University (Tomsk).